Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Nicotine Addiction - Pipeline Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 29 Aug 17

The "Nicotine Addiction - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Nicotine Addiction - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Nicotine Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Nicotine Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Nicotine Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 1, 11 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 5 and 1 molecules, respectively.

Key Topics Covered:

  1. Introduction
  2. Nicotine Addiction - Overview
  3. Nicotine Addiction - Therapeutics Development
  4. Pipeline Overview
  5. Pipeline by Companies
  6. Pipeline by Universities/Institutes
  7. Products under Development by Companies
  8. Products under Development by Universities/Institutes
  9. Nicotine Addiction - Therapeutics Assessment
  10. Assessment by Target
  11. Assessment by Mechanism of Action
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Nicotine Addiction - Companies Involved in Therapeutics Development
  • Addex Therapeutics Ltd
  • C4X Discovery Holdings PLC
  • Chronos Therapeutics Ltd
  • CV Sciences Inc
  • Hager Biosciences LLC
  • Heptares Therapeutics Ltd
  • Omeros Corp

For more information about this report visit https://www.researchandmarkets.com/research/d6ff8l/nicotine

View source version on businesswire.com: http://www.businesswire.com/news/home/20170829005628/en/

Business Wire
www.businesswire.com

Last updated on: 29/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.